SynerFuse named Adeel Khan, MD, as vice president of regenerative medicine, according to a March 24 news release shared with Becker’s.
Dr. Khan is a physician and regenerative medicine expert, and he was one of the first researchers in Canada to publish on intraosseous PRP.
“I am honored to serve as vice president of regenerative medicine at Synerfuse,” Dr. Khan said in the release. “This position enables me to concentrate on driving clinically informed innovation that delivers tangible improvements in patient outcomes while supporting the thoughtful adoption of new technologies. SynerFuse is taking an integrated approach that could reshape how clinicians manage one of the most common and debilitating conditions in healthcare.”
SynerFuse develops non-opioid solutions for patints with chronic lower back and lower leg pain.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
